These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

260 related items for PubMed ID: 24353218

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. The Prescription Drug User Fee Act of 1992: speeding up the drug approval process.
    Bierut MB.
    Healthspan; 1992 Dec; 9(11):12-4. PubMed ID: 10123552
    [No Abstract] [Full Text] [Related]

  • 5. New drug law to speed scientific review.
    Nature; 1992 Oct 15; 359(6396):563. PubMed ID: 1406977
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. FDA and drug safety: new Tufts study challenges critics of the Prescription Drug User Fee Act.
    Lee R.
    J Law Med Ethics; 2006 Oct 15; 34(1):131-4. PubMed ID: 16489994
    [No Abstract] [Full Text] [Related]

  • 10. User fees and beyond--the FDA Safety and Innovation Act of 2012.
    Kramer DB, Kesselheim AS.
    N Engl J Med; 2012 Oct 04; 367(14):1277-9. PubMed ID: 23034017
    [No Abstract] [Full Text] [Related]

  • 11. FDA dependence on drug industry.
    Lawson GW.
    J Natl Med Assoc; 2005 Jul 04; 97(7):1039-40. PubMed ID: 16080677
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Extending the User Fee Approach to Pharmaceuticals.
    Cutler DM.
    JAMA; 2018 Oct 16; 320(15):1525-1526. PubMed ID: 30326113
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Drug-review deadlines and safety problems.
    Carpenter D, Zucker EJ, Avorn J.
    N Engl J Med; 2008 Mar 27; 358(13):1354-61. PubMed ID: 18367738
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. How drugs are developed and approved by the FDA: current process and future directions.
    Ciociola AA, Cohen LB, Kulkarni P, FDA-Related Matters Committee of the American College of Gastroenterology.
    Am J Gastroenterol; 2014 May 27; 109(5):620-3. PubMed ID: 24796999
    [Abstract] [Full Text] [Related]

  • 18. FDA approvals of old drugs put new pressure on payers.
    Silverman E.
    Manag Care; 2011 May 27; 20(5):30-1. PubMed ID: 21667624
    [No Abstract] [Full Text] [Related]

  • 19. The prescription Drug User Fee Act of 1992 and the new drug development process.
    Kaitin KI.
    Am J Ther; 1997 May 27; 4(5-6):167-72. PubMed ID: 10423607
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.